What is carcinoid syndrome?
Carcinoid syndrome is a rare condition that happens if you have neuroendocrine tumors. Neuroendocrine tumors (NETs) are tumors that start in specialized cells in your neuroendocrine system.
NETs develop when your neuroendocrine cells begin to rapidly divide and multiply, creating tumors that release unusually large amounts of serotonin and other substances. When that happens, you develop carcinoid syndrome symptoms. Sometimes, a carcinoid syndrome diagnosis is the first indication you have a neuroendocrine tumor.
Very rarely, people with carcinoid syndrome have carcinoid crises, a potentially life-threatening condition that can happen if your carcinoid syndrome goes undiagnosed or untreated.
How is carcinoid syndrome treated?
Neuroendocrine tumors cause carcinoid syndrome, so treating the tumors also treats the syndrome.
Those treatments include:
- Surgery: Surgery to remove or reduce the size of the neuroendocrine tumors.
- Somatostatin analogs: Somatostatin analogs are drugs that may stop your body from making too many hormones. This may slow down the growth of the tumor when cancer cells spread to other parts of your body.
- Targeted therapy: Targeted therapy is a type of treatment that uses drugs that target certain genes or proteins to kill cancer cells.
- Chemotherapy: This treatment uses drugs that destroy cancer cells.
- Embolization: Embolization kills tumors by blocking or closing a blood vessel that feeds the tumor